mortality/aging
|
• despite being present at E12.5, no mice are present at E18.5
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Myh9tm1.1Dash targeted mutation 1.1, Tadashi Matsushita MGI:5551833 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• despite being present at E12.5, no mice are present at E18.5
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• despite being present at E12.5, fewer than expected mice are present at weaning
|
|
• abnormal proplatelet formation in cultured fetal liver-derived megakaryocytes
|
|
• more than twice the diameter of wild-type cells
|
|
• abnormal proplatelet formation in cultured fetal liver-derived megakaryocytes
|
|
• macrothrombocytopenia
|
| N |
• mice exhibit normal bleeding time and clot retraction
|
|
• severe at 5 weeks
• progressive
|
|
• severe at 5 weeks
• progressive
|
|
• mild segmental sclerosis to global sclerosis
|
| N |
• mice do not exhibit cataracts
|
|
• vacuole formation in the lens fibra at 20 weeks
|
| N |
• inner ear morphology is normal
|
|
• abnormal proplatelet formation in cultured fetal liver-derived megakaryocytes
|
|
• abnormal proplatelet formation in cultured fetal liver-derived megakaryocytes
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


